Migraine drug eptinezumab tested for Long-Term safety in japanese patients

NCT ID NCT05064371

Completed Disease control Sponsor: H. Lundbeck A/S Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at the long-term safety of eptinezumab, a drug given by IV infusion to prevent migraines. It included 160 Japanese patients who had already completed a previous study. The main goal was to see if the drug is safe and tolerable over 60 weeks of treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: eptinezumab
What this could lead to: If successful, this could confirm that eptinezumab is safe for long-term use to prevent migraines, offering a reliable treatment option.
What could go wrong: This is an extension study focused on safety, not on proving how well it works. It is also limited to Japanese participants, so results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MIGRAINE

Contacts and locations

Locations

Atsuchi Neurosurgery Hospital

Kagoshima, Kagoshima-ken, 892-0842, Japan
DOI Clinic Internal Medicine

Hiroshima-Shi Naka-Ku, Hiroshima, 730-0031, Japan
Dokkyo Medical University Hospital

Mibu-machi, 321-0293, Japan
Ikeda Neurosurgical Clinic

Kasuga-Shi, Hukuoka, 816-0824, Japan
Iwate Medical University Uchimaru Medical Center

Morioka, Iwate, 020-0023, Japan
Japanese Red Cross Shizuoka Hospital

Shizuoka, 420-0853, Japan
Jinnouchi Neurosurgery Clinic

Kasuga-Shi, Hukuoka, 816-0802, Japan
Mito Kyodo General Hospital

Mito, Ibaraki, 310-0015, Japan
Moriyama Neurological Center Hospital

Edogawa-Ku, Tokyo, 134-0085, Japan
Nagamitsu Clinic

Hofu-Shi, Yamaguchi, 747-0802, Japan
Saitama Neuropsychiatric Institute

Saitama-Shi, Saitama, 338-8577, Japan
Sendai Headache and Cranial Nerves Clinic

Sendai-Shi Taihaku-Ku, Miyagi, 982-0014, Japan
Shin Matsudakai Atago Hospital

Kochi, Kôti, 780-0051, Japan
Tatsuoka Neurology Clinic

Kyoto Shimojo-ku, 680-8811, Japan
Tokyo headache clinic

Shibuya-Ku, Tokyo, 151-0051, Japan
Tominaga Hospital

Osaka, Ã"saka, 556-0017, Japan
Toyota Memorial Hospital

Toyota-shi, 471-8513, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.